Linagliptin
Linagliptin (BI 1356) is a potent and orally bioavailable DPP-4 inhibitor of the dihydropurinedione class, used for its hypoglycemic effects. It is widely applied in diabetes research, including in vitro enzymatic assays and in vivo studies of glucose metabolism and pancreatic function.
Product Specifications
CAS Number
668270-12-0
Product Name Alternative
Dipeptidyl Peptidase, DPP, DPP4, DPP-4, Autophagy, BI 1356, BI1356, BI-1356, Inhibitor, Ferroptosis, inhibit, Linagliptin
Field of Research
Cell Biology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
99.15% (May vary between batches)
Solubility
Smiles
C (C#CC) N1C2=C (N=C1N3C[C@H] (N) CCC3) N (C) C (=O) N (CC4=NC5=C (C (C) =N4) C=CC=C5) C2=O
Molecular Formula
C25H28N8O2
Molecular Weight
472.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog